Join Us

We are 222,345 members in 83 forums discussing 162,466 topics.

Help with Abbreviations

Topic: BCO Podcast: Immunotherapy Updates

Forum: Immunotherapy - Before, During, and After —

Discuss your experiences with the benefits, risks, and side effects of immunotherapy treatment for breast cancer.

Posted on: Oct 1, 2019 11:19AM

Moderators wrote:

Where Are We With Immunotherapy for Breast Cancer? ESMO 2019 Coverage

September 27, 2019

Litton jennifer

Dr. Jennifer Litton is a board certified medical oncologist and professor of breast medical oncology at the University of Texas MD Anderson Cancer Center in Houston, where she is chief of the Section of Clinical Research and Drug Development for Breast Cancer. She also is a member of the Breast Immuno-Oncology Task Force of the National Cancer Institute.

At the European Society for Medical Oncology 2019 Congress, she presented information on a study she's leading, looking at combining a new type of immunotherapy with a traditional chemotherapy medicine. She joined us to talk about current immunotherapy research for breast cancer in general as well as what is specifically being presented at the congress.

Listen to the podcast to hear Dr. Litton discuss:

  • why immunotherapy medicines to treat breast cancer will likely be used with another type of therapy, such as chemotherapy or radiation therapy
  • the difference between a "hot" and "cold" tumor and why that is important for immunotherapy
  • other biomarkers besides PD-L1 that may help doctors decided if an immunotherapy medicine will work

Running time: 16:50

Listen now or read the transcript.

To send a Private Message to the Mods:
Log in to post a reply